Clinical Policy Title: Computerized gait analysis

Size: px
Start display at page:

Download "Clinical Policy Title: Computerized gait analysis"

Transcription

1 Clinical Policy Title: Computerized gait analysis Clinical Policy Number: Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: May 1, 2018 Next Review Date: May 2019 Related policies: Policy contains: Specialized laboratories. Gait dysfunction. Cerebral palsy. Orthopedic surgery. None. ABOUT THIS POLICY: Prestige Health Choice has developed clinical policies to assist with making coverage determinations. Prestige Health Choice s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peer-reviewed professional literature. These clinical policies, along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan-specific definition of medically necessary, and the specific facts of the particular situation are considered by Prestige Health Choice when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. Prestige Health Choice s clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. Prestige Health Choice s clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, Prestige Health Choice will update its clinical policies as necessary. Prestige Health Choice s clinical policies are not guarantees of payment. Coverage policy Prestige Health Choice considers the use of computerized gait analysis (also referred to as comprehensive motion analysis) to be clinically proven and, therefore, medically necessary for the evaluation of musculoskeletal function upon gait to aid in planning for orthopedic surgery or interventional neurology (e.g., nerve blocks to reduce spasticity orthotic application) in ambulatory members with certain gait dysfunction) (National Institute for Health and Care Excellence [NICE], 2012; Wren, 2009; 2013): Limitations: Cerebral palsy (CP). Meningomyelocele. Traumatic brain injury. Incomplete quadriplegia. Spastic hemiplegia. Spastic diplegia. 1

2 Coverage determinations are subject to benefit limitations and exclusions as delineated by the state Medicaid authority. The Florida Medicaid website may be accessed at All other uses of computerized gait analysis are not medically necessary. These services are payable only in a facility setting. Comprehensive computerized gait analysis studies are limited to one study performed once prior to planned intervention (e.g., surgery or nerve blocks to reduce spasticity orthotic application), and may be performed once after intervention to evaluate the results of the intervention. Alternative covered services: Observational clinical gait analysis. Background Gait and balance disorders are common in the elderly (where they constitute a significant contributor to falls), after orthopedic surgery, and in neurodevelopmental disorders such as spina bifida and CP. The clinical heterogeneity of gait disorders reflects the large and complex neuromuscular systems involved and the vulnerability of walking to neurologic disease at every level. Neurodevelopmental disorders are impairments of growth and development of the brain and central nervous system occurring in infancy or childhood that unfolds during the rest of life. These disorders have widespread effects that can impact such things as learning, memory, and other cognitive functions, as well as voluntary muscle control (coordination, mobility, speech articulation). Neurodevelopmental disorders are attributable to genetics, metabolic or infectious diseases, physical trauma, and toxic or other environmental exposures. Among the most common are CP and spinal bifida. Computerized or instrumented gait analysis: Providers have historically diagnosed and classified gait by observation, but common adaptation patterns to failing gaits, threatened stability, and declining performance cause classifications of gait to overlap or otherwise lack in discrimination. Standardized gait analysis in specialized laboratories equipped with cameras, floor sensors, and other equipment has been developed in response to the problems inherent in descriptive classification. Types of gait analysis include: comprehensive computer-based motion analysis by videotaping; threedimensional kinematics; dynamic plantar pressure measurements during walking; and dynamic surface electromyography of multiple muscles during walking or other functional activities. Gait analyses are used to diagnose, plan treatments, and evaluate outcomes. 2

3 Searches Prestige Health Choice searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality s National Guideline Clearinghouse and other evidence-based practice centers. The Centers for Medicare & Medicaid Services (CMS). We conducted searches on March 15, Search terms were: gait analysis, Gait Disorders, Neurologic/analysis [MeSH], Gait Disorders, Neurologic/diagnosis [MeSH], Cerebral Palsy/rehabilitation [MeSH], Cerebral Palsy/surgery [MeSH], and Spinal Dysraphism [MeSH]. We included: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. Findings Computerized three-dimensional gait analysis is promising for identifying individuals in need of preventive measures (for falling) or rehabilitation (for walking), but is a complex process producing vast amounts of data. Research is still defining those gait measures with the sensitivity and specificity likely to make them clinically useful. Thus, research is currently confined to its technical ability to provide necessary and accurate information for clinical decision making. While studies often show that gait analysis impacts decisions, many studies fail to address impacts on patient outcomes. Policy updates: In 2016, we identified no new evidence for this policy. We found one new CMS Local Coverage Determination that covers Florida, Puerto Rico, and the U.S. Virgin Islands and is reflected in the policy for Medicare members only. In 2017, we identified one evidence-based guideline from the National Collaborating Centre for Women's and Children's Health in the United Kingdom for this policy (NICE, 2012). The routine use of computerized gait analysis remains controversial. While it can alter decision making in some cases, it is less clear if the decisions based on computerized gait analysis lead to better patient outcomes. However, in ambulatory children with certain gait dysfunction (e.g., CP) who are candidates for orthopedic surgery, it can aid in 3

4 surgical planning by identifying common patterns of muscle overactivity and deformity and determining what type of muscle, tendon, or joint surgery would be most helpful. Therefore, this policy was amended to reflect this information. In 2018, no new evidence was identified. The guideline published by National Collaborating Centre for Women's and Children's Health (NICE, 2012) was updated in 2016 but the changes do not affect this coverage policy. The two CMS Local Coverage Determination documents that were previously included have both been retired. Summary of clinical evidence: Citation Wren (2013) Outcomes of lower extremity orthopedic surgery in ambulatory children with CP with and without gait analysis NICE (2012) Management of spasticity and co-existing motor disorders and their early musculoskeletal complications Hamacher (2011) Kinematic measures for gait stability in the elderly Wren (2011) Content, Methods, Recommendations A randomized controlled trial (RCT) of 83 children with gait analysis, 73 without. Outcomes assessed before surgery and 1.3 years post-operatively. Child Health Questionnaire showed improvement in 56% with report, 38% without. Pediatric Outcomes Data Collection Instrument for upper extremity showed better outcomes in patients whose surgeon received gait analysis report. On average, only 42% of recommendations based on gait report were followed versus 35% in the control group (p = 0.23). The decision to perform orthopedic surgery to improve gait should be informed by a thorough pre-operative functional assessment, preferably including gait analysis (either instrumented or video analysis). Systematic review of 29 relevant original articles, 1980 to March Best for distinguishing those at increased risk of falling from those at lower risk: linear variability of temporal measures for swing and stance, old versus young adults, width and stride velocities. Linear and non-linear measures of foot-time series during gait predict healthy versus fall-prone. Biomechanical measures promising for identifying individuals at risk of falling and can be obtained by relatively low-cost clinical assessment. Combined retrospective and prospective studies that incorporate the most promising measures for understanding fall risk and designing preventive strategies are warranted. Efficacy of clinical gait analysis Literature review of 116 studies that addressed technical feasibility of clinical gait analysis: 89 addressed diagnostic performance; 11 addressed impact on clinical diagnosis and treatment decision making; 7 addressed patient outcomes; 1 addressed impact on societal burden. All observational or non-randomized studies. Overall quality: unclear. 4

5 Citation Sharma (2009) Factors influencing early rehab after total hip arthroplasty Wren (2009) Effects of preoperative gait analysis on costs Hayes (2006) Content, Methods, Recommendations Greater volume of evidence for technical feasibility, diagnostic accuracy, impact of gait analysis on diagnosis and treatment decisions, but very limited evidence for its effect on patient outcome/cost-effectiveness without RCTs. Systematic review of 16 clinical trials (2,060 total subjects) with various interventions. Preoperative physical therapy, aggressive post-operative pain control and minimally invasive surgical procedures (but not gait analysis) improved functional recovery. 462 subjects with CP, 313/149 with/without gait analysis preoperatively. 11% and 32% of gait/non-gait subjects had additional surgeries. Costs per person-year were $916/$3,009 for gait/non-gait subjects. Rehabilitation of children with CP and spina bifida Systematic review of 12 studies: prospective controlled/comparative (6); prospective uncontrolled (1); case series (1); retrospective (4). Diagnoses: CP; 28 spina bifida; 57 post-surgical orthopedic. Assessment of surgical decisions or treatment planning in 87 subjects. Overall quality: low with high risk of bias. Most studies used Vicon motion analysis systems but number, placement of monitors, and data collect varied; overall, heterogeneity precluded analysis of consistency among outcomes. Sample sizes too small for valid comparisons among study groups and no usable orthopedic patient data. Limited evidence that gait analysis can distinguish normal versus abnormal gaits and may influence clinical decisions, but insufficient evidence to assess impact on continuum of care or outcomes. References Professional society guidelines/other: Cincinnati Children s Hospital Medical Center. Evidence-based care guideline for management of idiopathic toe walking in children and young adults ages 2 through 21 years. Cincinnati (OH): Cincinnati Children s Hospital Medical Center National Collaborating Centre for Women's and Children's Health. Spasticity in children and young people with non-progressive brain disorders. Management of spasticity and co-existing motor disorders and their early musculoskeletal complications. London (UK); 2012 Jul. Updated 2016 Nov. 54 p. (NICE clinical guideline; no. 145). National Institute for Health and Clinical Excellence (NICE) website. Accessed March 15, Peer-reviewed references: 5

6 Cimolin V, Galli M. Summary measures for clinical gait analysis: a literature review. Gait Posture. 2014; 39(4): Dobson F, Morris ME, Baker R, Graham HK. Gait classification in children with cerebral palsy: a systematic review. Gait Posture. 2007; 25(1): Hamacher D, Singh NB, Van Dieen JH, Heller MO, Taylor WR. Kinematic measures for assessing gait stability in elderly individuals: a systematic review. J R Soc Interface. 2011; 8(65): Hayes Inc., Hayes Medical Technology Report. Computerized gait analysis for cerebral palsy, spina bifida, and orthopedic disorders. Lansdale, Pa. Hayes Inc.; McClelland JA, Webster KE, Feller JA. Gait analysis of patients following total knee replacement: a systematic review. Knee. 2007; 14(4): Sharma V, Morgan PM, Cheng EY. Factors influencing early rehabilitation after THA: a systematic review. Clin Orthop Relat Res. 2009; 467(6): Wren TA, Gorton GE, 3rd, Ounpuu S, Tucker CA. Efficacy of clinical gait analysis: A systematic review. Gait Posture. 2011; 34(2): Wren TA, Kalisvaart MM, Ghatan CE, et al. Effects of preoperative gait analysis on costs and amount of surgery. J Pediatr Orthop. 2009; 29(6): Wren TA, Otsuka NY, Bowen RE, et al. Outcomes of lower extremity orthopedic surgery in ambulatory children with cerebral palsy with and without gait analysis: results of a randomized controlled trial. Gait Posture. 2013; 38(2): CMS National Coverage Determinations (NCDs): No NCDs were identified as of the writing of this policy. Local Coverage Determinations (LCDs): L33902 Comprehensive Motion Analysis Studies. CMS website. Accessed May 10, Note: this policy was retired for services rendered on or after May 10, L34310 Medicine: Physical Therapy Outpatient. CMS website. Accessed May 10, Note: this policy was retired for services rendered on or after February 17, Commonly submitted codes 6

7 Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill accordingly. CPT Code Description Comments Comprehensive computer-based motion analysis by videotaping and 3-D kinematics Comprehensive computer-based motion analysis by video-taping and 3-D kinematics; with dynamic plantar pressure measurements during walking Dynamic surface electromyography, during walking or other functional activities, 1-12 muscles Dynamic fine wire electromyography, during walking or other functional activities, 1 muscle Review and interpretation by physician or other qualified health care professional of comprehensive computer-based motion analysis dynamic plantar pressure measurements, dynamic surface electromyography during walking or other functional activities, and dynamic fine wire electromyography, with written report ICD-10 Code Description Comments G80.0-G80.9 Cerebral palsy G81.10-G81.14 Spastic hemiplegia G82.52 Incomplete quadriplegia, C1-C4 level G82.54 Incomplete quadriplegia, C5-C7 level Q05.0-Q05.9 Spina bifida Q07.00-Q07.03 Arnold-Chiari syndrome R26.1 Paralytic gait R26.81 Unsteadiness on feet R26.89 Other abnormalities of gait and mobility R26.9 Unspecified abnormalities of gait and mobility S06.1X0- S06.9X9S Traumatic brain injury HCPCS Level II Code N/A Description Comments 7

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 22, 2017 Next Review Date:

More information

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 17, 2015 Next Review Date:

More information

MOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS

MOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS Page: 1 of 5 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title COMPUTERIZED MOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS Policy Number 2.01.13 Category Technology Assessment Effective Date

More information

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy Title: Cardiac rehabilitation Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review

More information

Clinical Policy Title: Genicular nerve block

Clinical Policy Title: Genicular nerve block Clinical Policy Title: Genicular nerve block Clinical Policy Number: 14.01.10 Effective Date: October 1, 2017 Initial Review Date: September 21, 2017 Most Recent Review Date: October 19, 2017 Next Review

More information

Clinical Policy Title: Zoster (shingles) vaccine

Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Number: 18.02.10 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Clinical Policy Title: Strep testing

Clinical Policy Title: Strep testing Clinical Policy Title: Strep testing Clinical Policy Number: 07.01.09 Effective Date: December 1, 2017 Initial Review Date: October 19, 2017 Most Recent Review Date: November 16, 2017 Next Review Date:

More information

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Number: 17.02.02 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Subtalar arthroereisis (implant)

Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Number: 14.03.05 Effective Date: April 1, 2017 Initial Review Date: August 17, 2016 Most Recent Review Date: September 21, 2017 Next

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

IMPORTANT REMINDER DESCRIPTION

IMPORTANT REMINDER DESCRIPTION Medical Policy Manual Medicine, Policy No. 107 Gait Analysis Next Review: March 2019 Last Review: March 2018 Effective: April 1, 2018 IMPORTANT REMINDER Medical Policies are developed to provide guidance

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Clinical Policy Title: Discography

Clinical Policy Title: Discography Clinical Policy Title: Discography Clinical Policy Number: 03.01.01 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2017 Next Review Date: October

More information

Clinical Policy Title: Vacuum assisted closure in surgical wounds

Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: August 17,

More information

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Number: 01.01.03 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent

More information

Clinical Policy Title: Breast cancer index genetic testing

Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Number: 02.01.22 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2016

More information

Clinical Policy Title: Ketamine for treatment-resistant depression

Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

GAIT ANALYSIS. Policy Number: OUTPATIENT T2 Effective Date: June 1, Related Policies None

GAIT ANALYSIS. Policy Number: OUTPATIENT T2 Effective Date: June 1, Related Policies None GAIT ANALYSIS UnitedHealthcare Oxford Clinical Policy Policy Number: OUTPATIENT 039.11 T2 Effective Date: June 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF BUSINESS/PRODUCTS...

More information

Sympathetic Electrical Stimulation Therapy for Chronic Pain

Sympathetic Electrical Stimulation Therapy for Chronic Pain Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE

More information

Computerized gait analysis is considered medically necessary when BOTH of the following criteria are met:

Computerized gait analysis is considered medically necessary when BOTH of the following criteria are met: Medical Coverage Policy Effective Date... 4/15/2018 Next Review Date... 4/15/2019 Coverage Policy Number... 0315 Gait Analysis Table of Contents Coverage Policy... 1 Overview... 1 General Background...

More information

Gait Analysis Archived Medical Policy

Gait Analysis Archived Medical Policy Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Clinical Policy Title: Frenectomy for ankyloglossia

Clinical Policy Title: Frenectomy for ankyloglossia Clinical Policy Title: Frenectomy for ankyloglossia Clinical Policy Number: 11.03.03 Effective Date: October 1, 2014 Initial Review Date: April 16, 2014 Most Recent Review Date: May 18, 2016 Next Review

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

Clinical Policy Title: Tactile breast imaging

Clinical Policy Title: Tactile breast imaging Clinical Policy Title: Tactile breast imaging Clinical Policy Number: 05.01.07 Effective Date: February 1, 2018 Initial Review Date: November 16, 2017 Most Recent Review Date: January 11, 2018 Next Review

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review

More information

Clinical Policy Title: Bone growth stimulators for non-healing fractures

Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Number: 14.02.03 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: March

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2017 Next Review

More information

Clinical Policy Title: Actigraphy

Clinical Policy Title: Actigraphy Clinical Policy Title: Actigraphy Clinical Policy Number: 10.01.02 Effective Date: April 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date: November

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 11.03.05 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next

More information

Clinical Policy Title: Outpatient diabetes self-management training (DSMT)

Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: 06.02.02 Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March

More information

Clinical Policy Title: Spinal cord stimulators for chronic pain

Clinical Policy Title: Spinal cord stimulators for chronic pain Clinical Policy Title: Spinal cord stimulators for chronic pain Clinical Policy Number: 03.03.01 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date: April 19, 2017

More information

Clinical Policy Title: Investigational (experimental) health services

Clinical Policy Title: Investigational (experimental) health services Clinical Policy Title: Investigational (experimental) health services Clinical Policy Number: 18.04.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: September

More information

Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation

Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Number: 04.01.04 Policy contains: Effective Date: January 1, 2016 Initial Review Date September

More information

Clinical Policy Title: Room humidifiers

Clinical Policy Title: Room humidifiers Clinical Policy Title: Room humidifiers Clinical Policy Number: 17.02.05 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date:

More information

A Gillette Center of Excellence. Center for Gait and Motion Analysis. at Gillette Children s Specialty Healthcare

A Gillette Center of Excellence. Center for Gait and Motion Analysis. at Gillette Children s Specialty Healthcare A Gillette Center of Excellence Center for Gait and Motion Analysis at Gillette Children s Specialty Healthcare Centers of Excellence at Gillette Children s Specialty Healthcare Treating people who have

More information

Clinical Policy Title: Epidermal nerve fiber density testing

Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: CCP.1263 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 2, 2018

More information

Clinical Policy Title: Cryoneurolysis

Clinical Policy Title: Cryoneurolysis Clinical Policy Title: Cryoneurolysis Clinical Policy Number: 09.02.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: April 19, 2017 Next Review Date: April 2018

More information

Clinical Policy Title: Epidermal nerve fiber density testing

Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: 09.01.12 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19,

More information

Clinical Policy: Digital EEG Spike Analysis

Clinical Policy: Digital EEG Spike Analysis Clinical Policy: Reference Number: CP.MP.105 Last Review Date: 01/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Clinical Policy Title: Uvulopalatopharyngoplasty

Clinical Policy Title: Uvulopalatopharyngoplasty Clinical Policy Title: Uvulopalatopharyngoplasty Clinical Policy Number: 10.03.05 Effective Date: October 1, 2015 Initial Review Date: June 17, 2015 Most Recent Review Date: July 20, 2017 Next Review Date:

More information

Clinical Policy Title: Treatment of leg length discrepancy

Clinical Policy Title: Treatment of leg length discrepancy Clinical Policy Title: Treatment of leg length discrepancy Clinical Policy Number: 14.03.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January 18, 2017

More information

Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy

Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy Policy Number Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy 2017R0101E Annual Approval Date 7/13/2016 Approved By Payment Policy Oversight Committee IMPORTANT NOTE ABOUT

More information

Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy

Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy Clinical Policy Number: 02.01.23 Effective Date: February 1, 2017 Initial Review Date: January 18, 2017 Most Recent Review Date: January

More information

Clinical Policy Title: Seasonal influenza testing

Clinical Policy Title: Seasonal influenza testing Clinical Policy Title: Seasonal influenza testing Clinical Policy Number: 07.01.08 Effective Date: October 1, 2017 Initial Review Date: August 17, 2017 Most Recent Review Date: September 21, 2017 Next

More information

Clinical Policy Title: Hammer toe surgery

Clinical Policy Title: Hammer toe surgery Clinical Policy Title: Hammer toe surgery Clinical Policy Number: 18.03.04 Effective Date: July 1, 2016 Initial Review Date: July 15, 2016 Most Recent Review Date: May 1, 2018 Next Review Date: May 2019

More information

Clinical Policy Title: Genetic testing for Alzheimer s disease

Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Number: 02.01.20 Effective Date: July 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: May 19, 2017 Next

More information

Clinical Policy Title: Genetic testing for Alzheimer s disease

Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Number: 02.01.20 Effective Date: July 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: April 10, 2018 Next

More information

Physical Therapist Assistant Principles of Neuromuscular Rehabilitation

Physical Therapist Assistant Principles of Neuromuscular Rehabilitation Western Technical College 10524144 Physical Therapist Assistant Principles of Neuromuscular Rehabilitation Course Outcome Summary Course Information Description Career Cluster Instructional Level Total

More information

Clinical Policy Title: Epidermal nerve fiber density testing

Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: 09.01.12 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19,

More information

Clinical Policy Title: Genomic tests in neurology

Clinical Policy Title: Genomic tests in neurology Clinical Policy Title: Genomic tests in neurology Clinical Policy Number: 09.01.09 Effective Date: January 1, 2016 Initial Review Date: June 16, 2015 Most Recent Review Date: September 14, 2017 Next Review

More information

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Number: 02.02.01 Effective Date: October 1, 2015 Initial Review Date: April 15, 2015 Most Recent Review Date: May

More information

Clinical Policy Title: Bloodless heart transplant

Clinical Policy Title: Bloodless heart transplant Clinical Policy Title: Bloodless heart transplant Clinical Policy Number: 05.03.05 Effective Date: July 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next Review Date:

More information

Clinical Policy Title: Home phototherapy for hyperbilirubinemia

Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Number: 11.02.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17,

More information

Clinical Policy Title: Applied behavior analysis (ABA)

Clinical Policy Title: Applied behavior analysis (ABA) Clinical Policy Title: Applied behavior analysis (ABA) Clinical Policy Number: 11.04.03 Effective Date: October 1, 2015 Initial Review Date: May 15, 2015 Most Recent Review Date: June 15, 2016 Next Review

More information

Clinical Policy Title: Tilt table testing

Clinical Policy Title: Tilt table testing Clinical Policy Title: Tilt table testing Clinical Policy Number: CCP.1249 Effective Date: October 1, 2016 Initial Review Date: July 20, 2016 Most Recent Review Date: August 7, 2018 Next Review Date: August

More information

Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation

Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Number: 04.01.04 Effective Date: January 1, 2016 Initial Review Date September 16, 2015 Most

More information

Impact of gait analysis on correction of excessive hip internal rotation in ambulatory children with cerebral palsy: a randomized controlled trial

Impact of gait analysis on correction of excessive hip internal rotation in ambulatory children with cerebral palsy: a randomized controlled trial DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY ORIGINAL ARTICLE Impact of gait analysis on correction of excessive hip internal rotation in ambulatory children with cerebral palsy: a randomized controlled trial

More information

The Ultimate Biomechanics Lab

The Ultimate Biomechanics Lab myometricslab The Ultimate Biomechanics Lab ASSESSED, QUANTIFIED & VERIFIED Noraxon USA provides market-leading technology for measurement and training devices, such as EMG, gait analysis, biofeedback,

More information

Gait analysis and medical treatment strategy

Gait analysis and medical treatment strategy Gait analysis and medical treatment strategy Sylvain Brochard Olivier Rémy-néris, Mathieu Lempereur CHU and Pediatric Rehabilitation Centre Brest Course for European PRM trainees Mulhouse, October 22,

More information

Intrathecal Baclofen for CNS Spasticity

Intrathecal Baclofen for CNS Spasticity Intrathecal Baclofen for CNS Spasticity Last Review Date: October 13, 2017 Number: MG.MM.ME.31bC7 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary

More information

Reimbursement Guide. Physical Performance Testing For Balance Assessment. September 18 th, Copyright 2013 Sway Medical LLC

Reimbursement Guide. Physical Performance Testing For Balance Assessment. September 18 th, Copyright 2013 Sway Medical LLC Reimbursement Guide Physical Performance Testing For Balance Assessment September 18 th, 2013 The enclosed reimbursement recommendations are based on information gathered from thirdparty sources and is

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 1135 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: August 1, 2018 Next Review

More information

Clinical Policy Title: Pharmocogenetic testing for warfarin (Coumadin ) sensitivity

Clinical Policy Title: Pharmocogenetic testing for warfarin (Coumadin ) sensitivity Clinical Policy Title: Pharmocogenetic testing for warfarin (Coumadin ) sensitivity Clinical Policy Number: 02.01.13 Effective Date: September 1, 2013 Initial Review Date: May 15, 2013 Most Recent Review

More information

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy

More information

Clinical Policy Title: Statin use in adults and children

Clinical Policy Title: Statin use in adults and children Clinical Policy Title: Statin use in adults and children Clinical Policy Number: 04.02.09 Effective Date: May 1, 2016 Initial Review Date: February 17, 2016 Most Recent Review Date: September 21, 2017

More information

UTILIZING CPT AND HCPCS CODES FOR HEALTHCARE REIMBURSEMENT: A guide to billing and reimbursement of SpiderTech kinesiology tape products

UTILIZING CPT AND HCPCS CODES FOR HEALTHCARE REIMBURSEMENT: A guide to billing and reimbursement of SpiderTech kinesiology tape products UTILIZING CPT AND HCPCS CODES FOR HEALTHCARE REIMBURSEMENT: A guide to billing and reimbursement of SpiderTech kinesiology tape products Billing and coding of taping and strapping services can be a complex

More information

Clinical Policy Title: Radiofrequency ablation treatment for spine pain

Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: February

More information

CommonKnowledge. Pacific University. Leah Rybolt Pacific University. Recommended Citation. Notice to Readers

CommonKnowledge. Pacific University. Leah Rybolt Pacific University. Recommended Citation. Notice to Readers Pacific University CommonKnowledge PT Critically Appraised Topics School of Physical Therapy 2014 A comparison of strength training to standard care at Khayelitsha Special School in improving motor function

More information

Clinical Policy Title: Inhaled nitric oxide

Clinical Policy Title: Inhaled nitric oxide Clinical Policy Title: Inhaled nitric oxide Clinical Policy Number: 11.02.02 Effective Date: June 1 2014 Initial Review Date: February 19, 2014 Most Recent Review Date: May 17, 2017 Next Review Date: March

More information

Clinical Policy Title: Magnetoencephalography and magnetic source imaging

Clinical Policy Title: Magnetoencephalography and magnetic source imaging Clinical Policy Title: Magnetoencephalography and magnetic source imaging Clinical Policy Number: 09.01.07 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: July

More information

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Effective Date: 03/05 Last Review Date: 10/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Clinical Policy Title: Bronchial thermoplasty for severe asthma

Clinical Policy Title: Bronchial thermoplasty for severe asthma Clinical Policy Title: Bronchial thermoplasty for severe asthma Clinical Policy Number: 07.03.01 Effective Date: March 1, 2013 Initial Review Date: October 16, 2013 Most Recent Review Date: October 19,

More information

Physical Therapy MM /15/2003

Physical Therapy MM /15/2003 Physical Therapy Policy Number: Original Effective Date: MM.09.005 07/15/2003 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 06/23/2017 Line(s) of Business Excluded: Federal Employee

More information

Slide 1. Slide 2. Slide 3. Intro to Physical Therapy for Neuromuscular Conditions. PT Evaluation. PT Evaluation

Slide 1. Slide 2. Slide 3. Intro to Physical Therapy for Neuromuscular Conditions. PT Evaluation. PT Evaluation Slide 1 Intro to Physical Therapy for Neuromuscular Conditions PTA 103 Introduction to Clinical Practice 2 Slide 2 Mental status: consciousness, attention, orientation, cognition Communication: speech

More information

Methods Patients A retrospective review of gait studies was conducted for all participants presented to the Motion Analysis

Methods Patients A retrospective review of gait studies was conducted for all participants presented to the Motion Analysis 58 Original article Predictors of outcome of distal rectus femoris transfer surgery in ambulatory children with cerebral palsy Susan A. Rethlefsen a, Galen Kam d, Tishya A.L. Wren a,b,c and Robert M. Kay

More information

Clinical Policy: Radial Head Implant Reference Number: CP.MP.148

Clinical Policy: Radial Head Implant Reference Number: CP.MP.148 Clinical Policy: Reference Number: CP.MP.148 Effective Date: 08/17 Last Review Date: 08/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

Clinical Policy Title: Intralesional steroid injection for acne

Clinical Policy Title: Intralesional steroid injection for acne Clinical Policy Title: Intralesional steroid injection for acne Clinical Policy Number: 16.02.07 Effective Date: June 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: May 19, 2017 Next

More information

Gait & Posture. Efficacy of clinical gait analysis: A systematic review

Gait & Posture. Efficacy of clinical gait analysis: A systematic review Gait & Posture 34 (2011) 149 153 Contents lists available at ScienceDirect Gait & Posture journal homepage: www.elsevier.com/locate/gaitpost Review Efficacy of clinical gait analysis: A systematic review

More information

Clinical Policy Title: Neuromuscular reeducation

Clinical Policy Title: Neuromuscular reeducation Clinical Policy Title: Neuromuscular reeducation Clinical Policy Number: 15.02.10 Policy contains: Effective Date: January 1, 2017 Initial Review Date: September 21, 2016 Most Recent Review Date: September

More information

Clinical Policy Title: Tumor treatment fields for glioblastoma

Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Number: 05.02.05 Effective Date: July 1, 2015 Initial Review Date: March 18, 2015 Most Recent Review Date: April 19, 2017

More information

Clinical Policy Title: Pediatric rhinoplasty

Clinical Policy Title: Pediatric rhinoplasty Clinical Policy Title: Pediatric rhinoplasty Clinical Policy Number: 11.03.06 Effective Date: October 1, 2017 Initial Review Date: August 17, 2017 Most Recent Review Date: September 21, 2017 Next Review

More information

Clinical Policy Title: Vacuum assisted closure in surgical wounds

Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: July 3,

More information

Review of Selected Physical Therapy Interventions for School Age Children with Disabilities

Review of Selected Physical Therapy Interventions for School Age Children with Disabilities Review of Selected Physical Therapy Interventions for School Age Children with Disabilities Prepared for the Center on Personnel Studies in Special Education EXECUTIVE SUMMARY by Susan K. Effgen University.

More information

Clinical Policy Title: Radiofrequency ablation treatment for spine pain

Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: March

More information

Clinical Policy Title: Arthroscopic anterior cruciate ligament surgery skeletally immature

Clinical Policy Title: Arthroscopic anterior cruciate ligament surgery skeletally immature Clinical Policy Title: Arthroscopic anterior cruciate ligament surgery skeletally immature Clinical Policy Number: 14.03.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review

More information